NCT00350727View on ClinicalTrials.gov

Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma

PHASE2CompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Glioma

Interventions

DRUG

pazopanib

Pazopanib is a novel compound being developed for the treatment of various cancers.

DRUG

lapatinib

Lapatinib is a novel compound being developed for the treatment of various cancers.

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY